Thyroid cancer diagnostics market projected to reach $4.81 billion by 2032
From GlobeNewswire: 2025-02-25 09:30:00
The Thyroid Cancer Diagnostics Market was valued at USD 2.94 billion in 2023 and is projected to reach USD 4.81 billion by 2032, with a CAGR of 5.65%. Increasing incidence of thyroid cancer drives demand for more accurate diagnosis methods. New technologies like imaging and molecular tests improve accuracy and enable personalized treatment plans.
Major players in the market include Abbott Laboratories, Roche, Thermo Fisher Scientific, and Siemens Healthineers, among others. These companies offer a range of diagnostic tests and equipment for thyroid cancer detection and monitoring.
The market is segmented by type, technique, and end-use. Papillary carcinoma is the most common form of thyroid cancer, emphasizing the need for reliable diagnostic tools. Imaging modalities like ultrasound are common, while biopsy procedures are expected to grow due to their accuracy in differentiating benign from malignant nodules.
North America leads the thyroid cancer diagnostics market, with strong healthcare facilities and high awareness. The Asia Pacific region is poised for significant growth, driven by increased healthcare spending and adoption of new diagnostic technologies.
Recent developments in the market include GE Healthcare’s Revolution RT system for improved imaging precision, Roche’s Cobas Mass Spec solution for enhanced specificity in diagnostics, and the introduction of ThyroSeq v3 test for more accurate cancer diagnoses.
To stay updated on the latest trends and developments in the Thyroid Cancer Diagnostics Market, connect with our team of analysts for a detailed briefing session. Statistical insights and trends in thyroid cancer diagnostics include incidence and prevalence data from 2023-2032, diagnostic procedure trends in 2023 by region, adoption of advanced diagnostic technologies from 2020-2032 by region, healthcare spending on diagnostics in 2023 by region, regulatory trends and approvals from 2023-2032, and research & development trends. The competitive landscape, market analysis by type, technique, and end-use, regional analysis, company profiles, use cases, and best practices are also covered in the report. SNS Insider is a leading market research and consulting agency providing clients with current, accurate market data and insights to make informed decisions. For customized research on the thyroid cancer diagnostics market, enquire now.
Read more at GlobeNewswire: Thyroid Cancer Diagnostics Market to Reach USD 4.81 Billion